[1]
Brugnera Nunes de Mattos, A., Maria Cerneski, M., Reichert, S. and Nava Jaeger, C. 2023. Use of Adalimumab, a TNF-Alpha Inhibitor, is Associated with Paradoxical Psoriasis: Two Clinical Case Reports . Brazilian Journal of Case Reports. 3, 2 (Jan. 2023), 12–15. DOI:https://doi.org/10.52600/2763-583X.bjcr.2023.3.2.12-15.